Novel prenatal blood tests unveiled at the European Society of Human Reproduction and Embryology (ESHRE) reveal predictive biomarkers that identify preeclampsia and gestational diabetes mellitus (GDM) risk months before clinical onset. These discoveries, emerging from major studies conducted in San Francisco and presented at ESHRE, leverage molecular and environmental exposure data, potentially enabling earlier interventions to improve maternal and fetal outcomes.